Skip to main content

Table 1 Study population

From: Differences in systemic adaptive immunity contribute to the ‘frequent exacerbator’ COPD phenotype

Characteristics

Frequent exacerbation (n = 8)

Infrequent exacerbation (n = 16)

p

Age (years)

80.6 ± 11.2

74.1 ± 8.0

0.169

Gender (male)

6

11

0.751

Exacerbation Frequency (/y)

3.82 ± 0.92

1.70 ± 0.81

NA

Smoking Status (ex-smoker)

7

10

0.204

Pack years

51.6 ± 30.4

44.9 ± 26.7

0.605

FEV1 (L)

1.21 ± 0.47

1.54 ± 0.64

0.163

FVC (L)

2.41 ± 0.58

2.96 ± 0.86

0.079

FEV1 %pred (%)

52.6 ± 19.4

53.7 ± 18.4

0.892

FVC %pred (%)

91.1 ± 32.7

82.9 ± 18.7

0.527

FEV1/FVC

0.52 ± 0.20

0.51 ± 0.15

0.928

  1. Data expressed as mean ± SD except absolute number for gender and smoking status. Significance was calculated with chi-square or t test as appropriate. FEV 1 forced expiratory volume in 1 s, FVC forced vital capacity, %pred the percentage of predicted